Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
International Cancer Conference Journal|June 1, 2019
Gemcitabine and docetaxel in a patient with primary ovarian leiomyosarcoma: a case report and review of literatureYoko Furutake, Tomoyuki Fukagawa, Yasuko Suga, et al.
Gynecologic Oncology|August 14, 2024
Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysisAkira Yokoi, Hiroko Machida, Muneaki Shimada, et al.
International Journal of Clinical Oncology|January 22, 2026
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancerSho Sato, Masahiro Kagabu, Ami Jo, et al.
Cancer Chemotherapy and Pharmacology|March 4, 2014
A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, et al.
International Cancer Conference Journal|June 1, 2019
Advanced squamous cell carcinomas arising from mature cystic teratoma of the ovary: a retrospective case series at the Tohoku Gynecologic Cancer UnitHideki Tokunaga, Yoh Watanabe, Michiko Kaiho, et al.
Gynecologic Oncology|July 21, 2007
Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancerToshio Fujimoto, Hiroshi Nanjyo, Akira Nakamura, et al.
Oncology Reports|May 24, 2008
A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit StudyYoshihito Yokoyama, Tadao Takano, Kenji Nakahara, et al.
Anticancer Research|November 29, 2025
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective StudyEriko Takatori, Tadahiro Shoji, Ami Jo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 24, 2010
[Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer]Tadahiro Shoji, Eriko Takatori, Masatoshi Murai, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative studyHiroi Kaku, Seisuke Kumagai, Hiroki Onoue, et al.
Pageof 9